Ginkgo Bioworks Holdings, Inc. - 10-Q Filing
Ginkgo Bioworks filed a 10-Q for the quarter ended March 31, 2026, disclosing financial results and updates on its business operations. The filing includes details on cash and cash equivalents, marketable securities, and fair value measurements. It also outlines the disposition of its Ginkgo Biosecurity segment, which was sold on April 3, 2026.
Tickers: $DNA